Peripheral vascular disease

Cardiovascular disease and epidemiology

Cognitive function and age-associated cognitive decline

NESSIE - NIHR Evidence Synthesis Scotland Initiative: a collaboration between University of Edinburgh, Glasgow Caledonian University, University of Stirling and University of Newcastle Upon Tyne and patient representatives. We aim to produce high quality evidence syntheses across a wide range of topics relevant to health care, public health and social care. These will have a direct impact on decision-making, patient and client care reducing inequalities and identifiying future research needs. Our projects will provide best evidence to support decision-making across health, public health and social care in all four nations of the UK.

Cochrane Vascular: facilitating production of Cochrane systematic reviews on the diagnosis, prevention and treatment of peripheral arterial disease (including intermittent claudication and chronic limb threatening ischaemia), venous disease (including venous thromboembolism and varicose veins) and abdominal aortic aneurysm

Aspirin for Asymptomatic Aterosclerosis (AAA) Trial: large scale randomised controlled trial of aspirin in asymptomatic subjects with a low ankle brachial index. The effect of treatment on the development of clinical cardiovascular disease is investigated, as is the effect on overall mortality. In addition the effect of aspirin on age-associated congitive decline is investigated (PIs G Fowkes, J Price)

Edinburgh Artery Study (EAS): Study of genetic and non-genetic risk factors in the aetiology and prediction of vascular disease and peripheral arterial disease  (PIs G Fowkes, J Price)